C
ANIP icon

Covestor’s ANI Pharmaceuticals ANIP Stock Holding History

Covestor’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11K Buy
142
+26
+22% +$2.09K 0.01% 1481
2026
Q1 		$9K Buy
116
+4
+4% +$312 0.01% 1442
2025
Q4 		$9K Buy
112
+1
+0.9% +$87 ﹤0.01% 1606
2025
Q3 		$10K Buy
111
+109
+5,450% +$8.89K 0.01% 1584
2025
Q2 		$0 Hold
2
– – ﹤0.01% 2170
2025
Q1 		$0 Sell
2
-45
-96% -$2.69K ﹤0.01% 2178
2024
Q4 		$3K Buy
47
+29
+161% +$1.67K ﹤0.01% 1781
2024
Q3 		$1K Buy
18
+6
+50% +$366 ﹤0.01% 1884
2024
Q2 		$1K Buy
12
+1
+9% +$65 ﹤0.01% 1917
2024
Q1 		$1K Buy
11
+9
+450% +$543 ﹤0.01% 1893
2023
Q4 		$0 Hold
2
– – ﹤0.01% 2108
2023
Q3 		$0 Buy
+2
New +$115 ﹤0.01% 2079

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Covestor's ANIP Position: Q2 2026 in Review

Covestor increased its ANI Pharmaceuticals (ANIP) stake by 22% in Q2 2026, buying an estimated $2.09K and bringing the position to 142 shares worth $11K. The position accounts for 0.01% of the portfolio, ranked #1481.

Covestor first reported a position in ANIP in Q3 2023 and has held it in 12 quarters since. 307 funds tracked by Wall St. Rank hold ANIP as of Q2 2026.

  • Covestor held 142 shares of ANI Pharmaceuticals worth $11K as of Q2 2026.
  • Covestor bought 26 ANI Pharmaceuticals shares in Q2 2026, an estimated $2.09K.
  • ANI Pharmaceuticals made up 0.01% of Covestor's portfolio in Q2 2026, its #1481 holding.
  • Covestor first reported a position in ANI Pharmaceuticals in Q3 2023 and has held it in 12 quarters since.
  • 307 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2026.

Based on Covestor's 13F filing for Q2 2026, filed 7 Aug 2026.